Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

Cited In for PubMed (Select 14609465)

1.

Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013-14.

Funk A, Uadiale K, Kamau C, Caugant DA, Ango U, Greig J.

PLoS Curr. 2014 Dec 29;6. pii: ecurrents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518. doi: 10.1371/currents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518.

2.

Disease-associated Neisseria meningitidis isolates inhibit wound repair in respiratory epithelial cells in a type IV pilus-independent manner.

Ren X, MacKichan JK.

Infect Immun. 2014 Dec;82(12):5023-34. doi: 10.1128/IAI.02001-14. Epub 2014 Sep 15.

3.

Spatio-temporal factors associated with meningococcal meningitis annual incidence at the health centre level in Niger, 2004-2010.

Paireau J, Maïnassara HB, Jusot JF, Collard JM, Idi I, Moulia-Pelat JP, Mueller JE, Fontanet A.

PLoS Negl Trop Dis. 2014 May 22;8(5):e2899. doi: 10.1371/journal.pntd.0002899. eCollection 2014 May.

4.

An outbreak of serogroup C (ST-11) meningococcal disease in Tijuana, Mexico.

Chacon-Cruz E, Espinosa-De Los Monteros LE, Navarro-Alvarez S, Aranda-Lozano JL, Volker-Soberanes ML, Rivas-Landeros RM, Alvelais-Arzamendi AA, Vazquez JA.

Ther Adv Vaccines. 2014 May;2(3):71-6. doi: 10.1177/2051013614526592.

5.

Expression, purification and crystallization of acetyl-CoA hydrolase from Neisseria meningitidis.

Khandokar YB, Londhe A, Patil S, Forwood JK.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Nov;69(Pt 11):1303-6. doi: 10.1107/S1744309113028042. Epub 2013 Oct 30.

PMID:
24192375
6.

Knowledge, attitudes, and practices related to meningitis in northern Ghana.

Hayden MH, Dalaba M, Awine T, Akweongo P, Nyaaba G, Anaseba D, Pelzman J, Hodgson A, Pandya R.

Am J Trop Med Hyg. 2013 Aug;89(2):265-70. doi: 10.4269/ajtmh.12-0515. Epub 2013 Jun 17.

7.

Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt.

Tartof S, Cohn A, Tarbangdo F, Djingarey MH, Messonnier N, Clark TA, Kambou JL, Novak R, Diomandé FV, Medah I, Jackson ML.

PLoS One. 2013 May 9;8(5):e63605. doi: 10.1371/journal.pone.0063605. Print 2013.

8.

Meningococcal disease: changes in epidemiology and prevention.

Chang Q, Tzeng YL, Stephens DS.

Clin Epidemiol. 2012;4:237-45. doi: 10.2147/CLEP.S28410. Epub 2012 Sep 19.

9.

Impact of climate change on children's health in Limpopo Province, South Africa.

Thompson AA, Matamale L, Kharidza SD.

Int J Environ Res Public Health. 2012 Mar;9(3):831-54. doi: 10.3390/ijerph9030831. Epub 2012 Mar 8.

10.

Analysing spatio-temporal clustering of meningococcal meningitis outbreaks in Niger reveals opportunities for improved disease control.

Paireau J, Girond F, Collard JM, Maïnassara HB, Jusot JF.

PLoS Negl Trop Dis. 2012;6(3):e1577. doi: 10.1371/journal.pntd.0001577. Epub 2012 Mar 20.

11.

Meningococcal disease serogroup C.

Dickinson FO, Pérez AE, Cuevas IE.

Risk Manag Healthc Policy. 2012;5:1-15. doi: 10.2147/RMHP.S12711. Epub 2012 Mar 8.

12.

Spatial dynamics of meningococcal meningitis in Niger: observed patterns in comparison with measles.

Bharti N, Broutin H, Grais RF, Ferrari MJ, Djibo A, Tatem AJ, Grenfell BT.

Epidemiol Infect. 2012 Aug;140(8):1356-65. doi: 10.1017/S0950268811002032. Epub 2011 Oct 5.

13.

Neisseria meningitidis: biology, microbiology, and epidemiology.

Rouphael NG, Stephens DS.

Methods Mol Biol. 2012;799:1-20. doi: 10.1007/978-1-61779-346-2_1. Review.

14.

Epidemiology, molecular characterization and antibiotic resistance of Neisseria meningitidis from patients ≤15 years in Manhiça, rural Mozambique.

Ibarz-Pavón AB, Morais L, Sigaúque B, Mandomando I, Bassat Q, Nhacolo A, Quintó L, Soriano-Gabarró M, Alonso PL, Roca A.

PLoS One. 2011;6(6):e19717. doi: 10.1371/journal.pone.0019717. Epub 2011 Jun 10.

15.

Meningococcal disease and climate.

Palmgren H.

Glob Health Action. 2009 Nov 11;2. doi: 10.3402/gha.v2i0.2061. No abstract available.

16.

Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis.

Stephens DS.

Vaccine. 2009 Jun 24;27 Suppl 2:B71-7. doi: 10.1016/j.vaccine.2009.04.070. Epub 2009 May 23. Review.

17.

Relationships between climate and year-to-year variability in meningitis outbreaks: a case study in Burkina Faso and Niger.

Yaka P, Sultan B, Broutin H, Janicot S, Philippon S, Fourquet N.

Int J Health Geogr. 2008 Jul 2;7:34. doi: 10.1186/1476-072X-7-34.

18.

Epidemiology of severe Streptococcus pyogenes disease in Europe.

Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, Vuopio-Varkila J, Bouvet A, Creti R, Ekelund K, Koliou M, Reinert RR, Stathi A, Strakova L, Ungureanu V, Schalén C; Strep-EURO Study Group, Jasir A.

J Clin Microbiol. 2008 Jul;46(7):2359-67. doi: 10.1128/JCM.00422-08. Epub 2008 May 7.

19.

Atmospheric movement of microorganisms in clouds of desert dust and implications for human health.

Griffin DW.

Clin Microbiol Rev. 2007 Jul;20(3):459-77, table of contents. Review.

20.

Evaluation of the meningitis epidemics risk model in Africa.

Savory EC, Cuevas LE, Yassin MA, Hart CA, Molesworth AM, Thomson MC.

Epidemiol Infect. 2006 Oct;134(5):1047-51. Epub 2006 Feb 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk